C4 Therapeutics (CCCC) Long-Term Investments (2021 - 2025)
Historic Long-Term Investments for C4 Therapeutics (CCCC) over the last 5 years, with Q3 2025 value amounting to $7.9 million.
- C4 Therapeutics' Long-Term Investments fell 7261.73% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year decrease of 7261.73%. This contributed to the annual value of $22.4 million for FY2024, which is 2016.92% down from last year.
- As of Q3 2025, C4 Therapeutics' Long-Term Investments stood at $7.9 million, which was down 7261.73% from $8.4 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Long-Term Investments high stood at $142.2 million for Q4 2021, and its period low was $7.9 million during Q3 2025.
- In the last 5 years, C4 Therapeutics' Long-Term Investments had a median value of $32.5 million in 2021 and averaged $46.9 million.
- As far as peak fluctuations go, C4 Therapeutics' Long-Term Investments skyrocketed by 30153.25% in 2022, and later tumbled by 7844.14% in 2023.
- Over the past 5 years, C4 Therapeutics' Long-Term Investments (Quarter) stood at $142.2 million in 2021, then plummeted by 57.13% to $61.0 million in 2022, then plummeted by 54.06% to $28.0 million in 2023, then dropped by 20.17% to $22.4 million in 2024, then plummeted by 64.78% to $7.9 million in 2025.
- Its last three reported values are $7.9 million in Q3 2025, $8.4 million for Q2 2025, and $19.6 million during Q1 2025.